Evolving landscape of metastatic cancer survivorship: Reconsidering clinical care, policy, and research priorities for the modern era

Document Type

Other

Publication Title

Journal of Clinical Oncology

Volume

41

Issue

18

First Page

3304

Last Page

3310

PubMed ID

36848622

Publisher

American Society of Clinical Oncology

School

School of Medical and Health Sciences / Exercise Medicine Research Institute

RAS ID

58209

Comments

Lai-Kwon, J., Heynemann, S., Hart, N. H., Chan, R. J., Smith, T. J., Nekhlyudov, L., & Jefford, M. (2023). Evolving landscape of metastatic cancer survivorship: Reconsidering clinical care, policy, and research priorities for the modern era [Other]. Journal of Clinical Oncology, 41(18), 3304-3310. https://doi.org/10.1200/JCO.22.02212

Abstract

An individual may be considered a cancer survivor from diagnosis through the balance of their life. 1 In contrast to those with early-stage cancer, survivorship care for people with metastatic cancer has only recently begun to receive significant attention, 2-6 partly due to recent therapeutic advances and improvements in survival. There have been growing calls from patient advocates to address the unmet supportive care needs of people with metastatic cancer 4,7 and assurance that they and their caregivers be included within the definition of cancer survivor outlined by the National Coalition for Cancer Survivorship. . . .

DOI

10.1200/JCO.22.02212

Access Rights

free_to_read

Share

 
COinS